Treatment of rheumatic musculoskeletal disorders.

Buchanan WW, Rainsford KD, Kean CA, Kean WF

Open source

DOI
10.1007/s10787-023-01312-y
Published
2024 Feb
Container
Inflammopharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10787-023-01312-y,
  title = {Treatment of rheumatic musculoskeletal disorders.},
  author = {Buchanan WW and Rainsford KD and Kean CA and Kean WF},
  year = {2024},
  journal = {Inflammopharmacology},
  doi = {10.1007/s10787-023-01312-y},
  url = {https://doi.org/10.1007/s10787-023-01312-y}
}

RIS

TY  - JOUR
TI  - Treatment of rheumatic musculoskeletal disorders.
AU  - Buchanan WW
AU  - Rainsford KD
AU  - Kean CA
AU  - Kean WF
PY  - 2024
JO  - Inflammopharmacology
DO  - 10.1007/s10787-023-01312-y
UR  - https://doi.org/10.1007/s10787-023-01312-y
ER  - 

APA

WW, B., KD, R., CA, K., & WF, K. (2024). Treatment of rheumatic musculoskeletal disorders.. Inflammopharmacology. https://doi.org/10.1007/s10787-023-01312-y

Source records